
Soulquest Pharma Private Limited
Founded in February 2025 and headquartered in West Bengal, India.
Founded in February 2025 and headquartered in West Bengal, India.
Soulquest Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 February 2025 ( two months 14 days old ). Its registered office is in Howrah, West Bengal, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anita Singh and Deepak Singh serve as directors at the Company.
Howrah, West Bengal, India
+91-XXXXXXXXXX
U47721WB2025PTC276927
276927
Private Limited Indian Non-Government Company
27 Feb 2025
-
-
Unlisted
Roc Kolkata
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anita Singh ![]() | Director | 27-Feb-2025 | Current |
Deepak Singh ![]() | Director | 27-Feb-2025 | Current |
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Soulquest Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Deepak Singh is a mutual person
Anita Singh and Deepak Singh are mutual person
Anita Singh is a mutual person
Deepak Singh is a mutual person
Deepak Singh is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Soulquest Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Soulquest Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Soulquest Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Anita Singh was appointed as a Director was appointed as a Director on 27 Feb 2025 & has been associated with this company since 2 months 14 days .
Deepak Kumar Singh was appointed as a Director was appointed as a Director on 27 Feb 2025 & has been associated with this company since 2 months 14 days .
Soulquest Pharma Private Limited was registered on 27 Feb 2025 with Roc Kolkata & aged 2 months 14 days as per MCA records.
Soulquest Pharma Private Limited was incorporated on 27 Feb 2025.
The authorized share capital of Soulquest Pharma Private Limited is ₹ 1.50 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Soulquest Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Soulquest Pharma Private Limited is 1St-Fr; Fl- 101 266/4 G.T. Road, Liluah India, Uluberia - Ii, West Bengal, 711204.
The corporate identification number (CIN) of Soulquest Pharma Private Limited is U47721WB2025PTC276927 and the company number is 276927 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.